165 related articles for article (PubMed ID: 21193252)
1. Molecular modeling study and synthesis of quinazolinone-arylpiperazine derivatives as α1-adrenoreceptor antagonists.
Abou-Seri SM; Abouzid K; Abou El Ella DA
Eur J Med Chem; 2011 Feb; 46(2):647-58. PubMed ID: 21193252
[TBL] [Abstract][Full Text] [Related]
2. Computer--based drug design, synthesis and biological evaluation of new pyrimidinone derivatives linked to arylpiperazine and 2'-carbethoxy-biphenylylmethyl moeities as alpha1-adrenoceptor antagonists and angiotensin II AT1 receptor antagonists.
Ismail MA; Abou El Ella DA; Abouzid KA; Al-Ansary GH
Pharmazie; 2010 Nov; 65(11):794-800. PubMed ID: 21155384
[TBL] [Abstract][Full Text] [Related]
3. α-Adrenoceptor antagonistic and hypotensive properties of novel arylpiperazine derivatives of pyrrolidin-2-one.
Zaręba P; Dudek M; Lustyk K; Siwek A; Starowicz G; Bednarski M; Nowiński L; Raźny K; Sapa J; Malawska B; Kulig K
Bioorg Med Chem; 2015 May; 23(9):2104-11. PubMed ID: 25813897
[TBL] [Abstract][Full Text] [Related]
4. Studies on novel pyridine and 2-pyridone derivatives of N-arylpiperazine as α-adrenoceptor ligands.
Baran M; Kepczyńska E; Zylewski M; Siwek A; Bednarski M; Cegła MT
Med Chem; 2014 Mar; 10(2):144-53. PubMed ID: 23627274
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and α1-adrenoceptor antagonist activity of tamsulosin analogues.
Sagratini G; Angeli P; Buccioni M; Gulini U; Marucci G; Melchiorre C; Poggesi E; Giardinà D
Eur J Med Chem; 2010 Dec; 45(12):5800-7. PubMed ID: 20934789
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of new arylpiperazine derivatives bearing a flavone moiety as α1-adrenoceptor antagonists.
Jin J; Wang XB; Kong LY
Bioorg Med Chem Lett; 2011 Feb; 21(3):909-11. PubMed ID: 21236664
[TBL] [Abstract][Full Text] [Related]
7. Molecular design and synthesis of 1,4-disubstituted piperazines as α(1)-adrenergic receptor blockers.
Abou El-Ella DA; Hussein MM; Serya RA; Abdel Naby RM; Al-Abd AM; Saleh DO; El-Eraky WI; Abouzid KA
Bioorg Chem; 2014 Jun; 54():21-30. PubMed ID: 24727279
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, alpha-adrenoceptors affinity and alpha 1-adrenoceptor antagonistic properties of some 1,4-substituted piperazine derivatives.
Marona H; Kubacka M; Filipek B; Siwek A; Dybała M; Szneler E; Pociecha T; Gunia A; Waszkielewicz AM
Pharmazie; 2011 Oct; 66(10):733-9. PubMed ID: 22026152
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and alpha1-adrenoreceptor blocking activity of new arylpiperazines containing acetophenone substituents.
Huang JJ; Huang YJ; Zhu L; Yuan M; Huang L
Pharmazie; 2014 Aug; 69(8):578-84. PubMed ID: 25158567
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure-activity relationships of a new model of arylpiperazines. 4. 1-[omega-(4-Arylpiperazin-1-yl)alkyl]-3-(diphenylmethylene) - 2, 5-pyrrolidinediones and -3-(9H-fluoren-9-ylidene)-2, 5-pyrrolidinediones: study of the steric requirements of the terminal amide fragment on 5-HT1A affinity/selectivity.
López-Rodríguez ML; Morcillo MJ; Rovat TK; Fernández E; Vicente B; Sanz AM; Hernández M; Orensanz L
J Med Chem; 1999 Jan; 42(1):36-49. PubMed ID: 9888831
[TBL] [Abstract][Full Text] [Related]
11. The hypotensive activity and alpha1-adrenoceptor antagonistic properties of some aroxyalkyl derivatives of 2-methoxyphenylpiperazine.
Kubacka M; Mogilski S; Filipek B; Marona H
Eur J Pharmacol; 2013 Jan; 698(1-3):335-44. PubMed ID: 23117089
[TBL] [Abstract][Full Text] [Related]
12. Antiarrhythmic and α-Adrenoceptor Antagonistic Properties of Novel Arylpiperazine Derivatives of Pyrrolidin-2-one.
Zaręba P; Dudek M; Lustyk K; Siwek A; Starowicz G; Bednarski M; Nowiński L; Zygmunt M; Sapa J; Malawska B; Kulig K
Arch Pharm (Weinheim); 2015 Dec; 348(12):861-7. PubMed ID: 26523954
[TBL] [Abstract][Full Text] [Related]
13. Search for influence of spatial properties on affinity at α1-adrenoceptor subtypes for phenylpiperazine derivatives of phenytoin.
Handzlik J; Pertz HH; Görnemann T; Jähnichen S; Kieć-Kononowicz K
Bioorg Med Chem Lett; 2010 Oct; 20(20):6152-6. PubMed ID: 20813529
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, alpha 1-adrenoceptor antagonist activity, and SAR study of novel arylpiperazine derivatives of phenytoin.
Handzlik J; Maciag D; Kubacka M; Mogilski S; Filipek B; Stadnicka K; Kieć-Kononowicz K
Bioorg Med Chem; 2008 Jun; 16(11):5982-98. PubMed ID: 18490167
[TBL] [Abstract][Full Text] [Related]
15. Studies on quinazolines and 1,2,4-benzothiadiazine 1,1-dioxides. 8.1, 2 synthesis and pharmacological evaluation of tricyclic fused quinazolines and 1,2,4-benzothiadiazine 1,1-dioxides as potential alpha1-adrenoceptor antagonists.
Chern JW; Tao PL; Wang KC; Gutcait A; Liu SW; Yen MH; Chien SL; Rong JK
J Med Chem; 1998 Aug; 41(17):3128-41. PubMed ID: 9703460
[TBL] [Abstract][Full Text] [Related]
16. The possible mechanism of hypotensive activity of some pyrrolidin-2-one derivatives with antagonist properties at alpha1-adrenoceptors.
Sapa J; Kubacka M
Eur J Pharmacol; 2011 Dec; 673(1-3):40-8. PubMed ID: 21605554
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxy-propyl]-3,3-diphenylpyrrolidin-2-one derivatives with antiarrhythmic, antihypertensive, and alpha-adrenolytic activity.
Kulig K; Sapa J; Nowaczyk A; Filipek B; Malawska B
Eur J Med Chem; 2009 Oct; 44(10):3994-4003. PubMed ID: 19447527
[TBL] [Abstract][Full Text] [Related]
18. Novel naftopidil-related derivatives and their biological effects as alpha1-adrenoceptors antagonists and antiproliferative agents.
Huang J; He F; Huang M; Liu X; Xiong Y; Huang Y; Zhu L; Yang Y; Xu X; Yuan M
Eur J Med Chem; 2015; 96():83-91. PubMed ID: 25874333
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of novel 7-mercaptocoumarin derivatives as α(1)-adrenoceptor antagonists.
Xie SS; Wang XB; Li JY; Kong LY
Chem Pharm Bull (Tokyo); 2013; 61(1):16-24. PubMed ID: 23302583
[TBL] [Abstract][Full Text] [Related]
20. Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.
Asagarasu A; Matsui T; Hayashi H; Tamaoki S; Yamauchi Y; Minato K; Sato M
J Med Chem; 2010 Nov; 53(21):7549-63. PubMed ID: 20931963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
